Table 4 PS, PDI, ZP and drug retention % of FST-loaded LPHNPs aqueous dispersions (F3) stored at refrigerated (4 ± 1 °C) and ambient conditions (See Table 1 for F3 composition). Each value represents the ± SD (n = 3). * Significant at p < 0.05 monthly vs. initial, ** Highly significant at p < 0.01 monthly vs. initial, *** Extremely significant at p < 0.001 monthly vs. initial, ### Extremely significant at p < 0.001 refrigerated temperature vs. ambient temperature after 6 months.
Storage time | Evaluation parameters | |||||||
|---|---|---|---|---|---|---|---|---|
Refrigerated temperature (4 ± 1 °C) | Ambient temperature | |||||||
PS (nm) | PDI | ZP (mV) | Drug retention (%) | PS (nm) | PDI | ZP (mV) | Drug retention (%) | |
Zero time | 125.39 ± 0.924 | 0.357 ± 0.012 | + 30.16 ± 1.418 | 100.00 ± 0.000 | 125.39 ± 0.924 | 0.357 ± 0.012 | + 30.16 ± 1.41 | 100.00 ± 0.000 |
1 month | 119.42 ± 0.716 | 0.351 ± 0.014 | + 29.82 ± 1.722 | 99.72 ± 4.573 | 137.19 ± 2.709 | 0.382 ± 0.078 | + 25.56 ± 3.006 | 92.07 ± 1.226 |
2 month | 118.67 ± 2.082 | 0.334 ± 0.028 | + 30.09 ± 2.610 | 94.34 ± 0.566 | 147.05 ± 0.172*** | 0.359 ± 0.055 | + 22.51 ± 2.789** | 86.33 ± 8.572 |
3 month | 121.33 ± 2.041 | 0.311 ± 0.005 | + 28.67 ± 3.396 | 93.05 ± 2.218 | 184.16 ± 4.092*** | 0.588 ± 0.132** | + 20.99 ± 0.985*** | 84.44 ± 2.673 |
4 month | 117.33 ± 3.451 | 0.412 ± 0.004 | + 28.54 ± 1.592 | 92.86 ± 4.962 | 205.75 ± 4.549*** | 0.608 ± 0.084*** | + 20.27 ± 0.231*** | 74.63 ± 6.302* |
5 month | 123.05 ± 3.595 | 0.342 ± 0.0.03 | + 30.29 ± 1.041 | 92.11 ± 0.247 | 223.00 ± 2.564*** | 0.673 ± 0.071*** | + 18.35 ± 2.394*** | 72.59 ± 5.711** |
6 month | 120.95 ± 1.624### | 0.366 ± 0.038### | + 29.96 ± 0.613### | 90.42 ± 4.892### | 239.45 ± 3.743*** | 0.733 ± 0.044*** | + 14.04 ± 1.977*** | 67.81 ± 4.267** |